Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Limitations of clinical platinum(II) therapeutics include systemic toxicity and inherent resistance. Modern approaches therefore seek new ways to deliver active platinum(II) to discrete nucleic acid targets. In the field of antigene therapy, triplex forming oligonucleotides (TFOs) have attracted interest for their ability to specifically recognise extended duplex DNA targets. Here, we report a click chemistry-based approach that combines alkyne-modified TFOs with azide-bearing cis-platinum(II) complexes-based on cisplatin, oxaliplatin, and carboplatin motifs-to generate a library of Pt(II)-TFO hybrids. These constructs can be assembled modularly and enable directed platinum(II) crosslinking to purine nucleobases on the target sequence under the guidance of the TFO. By covalently incorporating modifications of thiazole orange-a known DNA intercalating fluorophore-into Pt(II)-TFOs constructs, enhanced target binding and discrimination between target and  off -target sequences was achieved.

Original publication

DOI

10.1002/anie.202110455

Type

Journal article

Journal

Angew Chem Int Ed Engl

Publication Date

15/10/2021

Keywords

Crosslinking, DNA Triplex, DNA hybrids, Platinum, click chemistry